Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vir, GSK’s COVID-19 antibody treatment works against omicron in a lab study, and WHO no longer recommends convalescent plasma By: MarketWatch December 07, 2021 at 10:31 AM EST Vir Biotechnology and GlaxoSmithKline’s COVID-19 antibody treatment worked against omicron in a laboratory study. Read More >> Related Stocks: Eli Lilly Gsk Plc ADR Regeneron Pharmaceuticals Vir Biotechnology Inc Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Vir, GSK’s COVID-19 antibody treatment works against omicron in a lab study, and WHO no longer recommends convalescent plasma By: MarketWatch December 07, 2021 at 10:31 AM EST Vir Biotechnology and GlaxoSmithKline’s COVID-19 antibody treatment worked against omicron in a laboratory study. Read More >> Related Stocks: Eli Lilly Gsk Plc ADR Regeneron Pharmaceuticals Vir Biotechnology Inc
